@lupusla: At Lupus LA’s #LatestOnLupus Conference at UCLA, Dr. Daniel Wallace shared emerging insights into the use of GLP-1 receptor agonists - commonly used to treat type 2 diabetes and obesity - in the possible management of lupus. 💡 Here’s what you should know: • GLP-1 drugs may offer anti-inflammatory benefits • Some studies suggest potential renal-protective effects • While more research is needed, these therapies may be part of a future, multidisciplinary approach to lupus care Dr. Wallace emphasized that these aren’t standard lupus treatments yet, but the ongoing exploration shows promise. Stay tuned as the science continues to evolve, and always speak with your doctor before considering new medications.🧑‍⚕️ 🎥 Watch the full replay of our 2025 #LatestOnLupus Conference at UCLA, and learn from Dr. Wallace’s session “New Treatments: What’s Next In Lupus" at YouTube.com/LupusLA #LupusLA #LatestOnLupus2025 #lupusnephritis #YourStoryOurFight #LupusAwareness #Lupus

LupusLA

Open In TikTok:

Region: US

Thursday 10 July 2025 18:53:30 GMT